[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Enoxaparin Sodium APIs and Preparations Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

April 2023 | 107 pages | ID: G719588E6284EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Enoxaparin Sodium APIs and Preparations market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Enoxaparin Sodium APIs and Preparations market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Enoxaparin Sodium APIs and Preparations market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Enoxaparin Sodium APIs and Preparations market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Enoxaparin Sodium APIs and Preparations market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Enoxaparin Sodium APIs and Preparations market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Enoxaparin Sodium APIs and Preparations

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Enoxaparin Sodium APIs and Preparations market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong Haike Chemical Group Co., Ltd, Manus Aktteva Biopharma LLP, Chemi SPA, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. and Venus Remedies Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Enoxaparin Sodium APIs and Preparations market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • 20 mg/0.2mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Market segment by Application
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Others
Major players covered
  • Shandong Haike Chemical Group Co., Ltd
  • Manus Aktteva Biopharma LLP
  • Chemi SPA
  • Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
  • Venus Remedies Ltd
  • JoinHub Pharma
  • Memphis Vision Care
  • Shenzhen Techdow Pharmaceutical Co., Ltd.
  • Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
  • Meithal Pharmaceuticals
  • Gland Pharma
  • Dongying Tiandong Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Enoxaparin Sodium APIs and Preparations product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Enoxaparin Sodium APIs and Preparations, with price, sales, revenue and global market share of Enoxaparin Sodium APIs and Preparations from 2018 to 2023.

Chapter 3, the Enoxaparin Sodium APIs and Preparations competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Enoxaparin Sodium APIs and Preparations breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Enoxaparin Sodium APIs and Preparations market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Enoxaparin Sodium APIs and Preparations.

Chapter 14 and 15, to describe Enoxaparin Sodium APIs and Preparations sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Enoxaparin Sodium APIs and Preparations
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 20 mg/0.2mL
  1.3.3 40 mg/0.4mL
  1.3.4 60 mg/0.6mL
  1.3.5 80 mg/0.8mL
  1.3.6 100 mg/1mL
  1.3.7 120 mg/0.8mL
  1.3.8 150 mg/1mL
  1.3.9 300mg/3mL
1.4 Market Analysis by Application
  1.4.1 Overview: Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Deep Vein Thrombosis
  1.4.3 Pulmonary Embolism
  1.4.4 Others
1.5 Global Enoxaparin Sodium APIs and Preparations Market Size & Forecast
  1.5.1 Global Enoxaparin Sodium APIs and Preparations Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Enoxaparin Sodium APIs and Preparations Sales Quantity (2018-2029)
  1.5.3 Global Enoxaparin Sodium APIs and Preparations Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Shandong Haike Chemical Group Co., Ltd
  2.1.1 Shandong Haike Chemical Group Co., Ltd Details
  2.1.2 Shandong Haike Chemical Group Co., Ltd Major Business
  2.1.3 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Product and Services
  2.1.4 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Shandong Haike Chemical Group Co., Ltd Recent Developments/Updates
2.2 Manus Aktteva Biopharma LLP
  2.2.1 Manus Aktteva Biopharma LLP Details
  2.2.2 Manus Aktteva Biopharma LLP Major Business
  2.2.3 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Product and Services
  2.2.4 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
2.3 Chemi SPA
  2.3.1 Chemi SPA Details
  2.3.2 Chemi SPA Major Business
  2.3.3 Chemi SPA Enoxaparin Sodium APIs and Preparations Product and Services
  2.3.4 Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Chemi SPA Recent Developments/Updates
2.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
  2.4.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Details
  2.4.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Major Business
  2.4.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
  2.4.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments/Updates
2.5 Venus Remedies Ltd
  2.5.1 Venus Remedies Ltd Details
  2.5.2 Venus Remedies Ltd Major Business
  2.5.3 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Product and Services
  2.5.4 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Venus Remedies Ltd Recent Developments/Updates
2.6 JoinHub Pharma
  2.6.1 JoinHub Pharma Details
  2.6.2 JoinHub Pharma Major Business
  2.6.3 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Product and Services
  2.6.4 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 JoinHub Pharma Recent Developments/Updates
2.7 Memphis Vision Care
  2.7.1 Memphis Vision Care Details
  2.7.2 Memphis Vision Care Major Business
  2.7.3 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Product and Services
  2.7.4 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Memphis Vision Care Recent Developments/Updates
2.8 Shenzhen Techdow Pharmaceutical Co., Ltd.
  2.8.1 Shenzhen Techdow Pharmaceutical Co., Ltd. Details
  2.8.2 Shenzhen Techdow Pharmaceutical Co., Ltd. Major Business
  2.8.3 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
  2.8.4 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments/Updates
2.9 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
  2.9.1 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Details
  2.9.2 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Major Business
  2.9.3 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
  2.9.4 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments/Updates
2.10 Meithal Pharmaceuticals
  2.10.1 Meithal Pharmaceuticals Details
  2.10.2 Meithal Pharmaceuticals Major Business
  2.10.3 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Product and Services
  2.10.4 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Meithal Pharmaceuticals Recent Developments/Updates
2.11 Gland Pharma
  2.11.1 Gland Pharma Details
  2.11.2 Gland Pharma Major Business
  2.11.3 Gland Pharma Enoxaparin Sodium APIs and Preparations Product and Services
  2.11.4 Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Gland Pharma Recent Developments/Updates
2.12 Dongying Tiandong Pharmaceutical Co., Ltd.
  2.12.1 Dongying Tiandong Pharmaceutical Co., Ltd. Details
  2.12.2 Dongying Tiandong Pharmaceutical Co., Ltd. Major Business
  2.12.3 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
  2.12.4 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: ENOXAPARIN SODIUM APIS AND PREPARATIONS BY MANUFACTURER

3.1 Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Manufacturer (2018-2023)
3.2 Global Enoxaparin Sodium APIs and Preparations Revenue by Manufacturer (2018-2023)
3.3 Global Enoxaparin Sodium APIs and Preparations Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Enoxaparin Sodium APIs and Preparations by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Enoxaparin Sodium APIs and Preparations Manufacturer Market Share in 2022
  3.4.2 Top 6 Enoxaparin Sodium APIs and Preparations Manufacturer Market Share in 2022
3.5 Enoxaparin Sodium APIs and Preparations Market: Overall Company Footprint Analysis
  3.5.1 Enoxaparin Sodium APIs and Preparations Market: Region Footprint
  3.5.2 Enoxaparin Sodium APIs and Preparations Market: Company Product Type Footprint
  3.5.3 Enoxaparin Sodium APIs and Preparations Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Enoxaparin Sodium APIs and Preparations Market Size by Region
  4.1.1 Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2018-2029)
  4.1.2 Global Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2018-2029)
  4.1.3 Global Enoxaparin Sodium APIs and Preparations Average Price by Region (2018-2029)
4.2 North America Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029)
4.3 Europe Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029)
4.4 Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029)
4.5 South America Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029)
4.6 Middle East and Africa Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
5.2 Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type (2018-2029)
5.3 Global Enoxaparin Sodium APIs and Preparations Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
6.2 Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application (2018-2029)
6.3 Global Enoxaparin Sodium APIs and Preparations Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
7.2 North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
7.3 North America Enoxaparin Sodium APIs and Preparations Market Size by Country
  7.3.1 North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2029)
  7.3.2 North America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
8.2 Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
8.3 Europe Enoxaparin Sodium APIs and Preparations Market Size by Country
  8.3.1 Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2029)
  8.3.2 Europe Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Enoxaparin Sodium APIs and Preparations Market Size by Region
  9.3.1 Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
10.2 South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
10.3 South America Enoxaparin Sodium APIs and Preparations Market Size by Country
  10.3.1 South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2029)
  10.3.2 South America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Enoxaparin Sodium APIs and Preparations Market Size by Country
  11.3.1 Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Enoxaparin Sodium APIs and Preparations Market Drivers
12.2 Enoxaparin Sodium APIs and Preparations Market Restraints
12.3 Enoxaparin Sodium APIs and Preparations Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Enoxaparin Sodium APIs and Preparations and Key Manufacturers
13.2 Manufacturing Costs Percentage of Enoxaparin Sodium APIs and Preparations
13.3 Enoxaparin Sodium APIs and Preparations Production Process
13.4 Enoxaparin Sodium APIs and Preparations Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Enoxaparin Sodium APIs and Preparations Typical Distributors
14.3 Enoxaparin Sodium APIs and Preparations Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Shandong Haike Chemical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Shandong Haike Chemical Group Co., Ltd Major Business
Table 5. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Product and Services
Table 6. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Shandong Haike Chemical Group Co., Ltd Recent Developments/Updates
Table 8. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 9. Manus Aktteva Biopharma LLP Major Business
Table 10. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Product and Services
Table 11. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 13. Chemi SPA Basic Information, Manufacturing Base and Competitors
Table 14. Chemi SPA Major Business
Table 15. Chemi SPA Enoxaparin Sodium APIs and Preparations Product and Services
Table 16. Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chemi SPA Recent Developments/Updates
Table 18. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Major Business
Table 20. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
Table 21. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 23. Venus Remedies Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Venus Remedies Ltd Major Business
Table 25. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Product and Services
Table 26. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Venus Remedies Ltd Recent Developments/Updates
Table 28. JoinHub Pharma Basic Information, Manufacturing Base and Competitors
Table 29. JoinHub Pharma Major Business
Table 30. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Product and Services
Table 31. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JoinHub Pharma Recent Developments/Updates
Table 33. Memphis Vision Care Basic Information, Manufacturing Base and Competitors
Table 34. Memphis Vision Care Major Business
Table 35. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Product and Services
Table 36. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Memphis Vision Care Recent Developments/Updates
Table 38. Shenzhen Techdow Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Shenzhen Techdow Pharmaceutical Co., Ltd. Major Business
Table 40. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
Table 41. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 43. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Major Business
Table 45. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
Table 46. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 48. Meithal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Meithal Pharmaceuticals Major Business
Table 50. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Product and Services
Table 51. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Meithal Pharmaceuticals Recent Developments/Updates
Table 53. Gland Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Gland Pharma Major Business
Table 55. Gland Pharma Enoxaparin Sodium APIs and Preparations Product and Services
Table 56. Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Gland Pharma Recent Developments/Updates
Table 58. Dongying Tiandong Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Dongying Tiandong Pharmaceutical Co., Ltd. Major Business
Table 60. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Product and Services
Table 61. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Enoxaparin Sodium APIs and Preparations Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Enoxaparin Sodium APIs and Preparations Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Enoxaparin Sodium APIs and Preparations, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Enoxaparin Sodium APIs and Preparations Production Site of Key Manufacturer
Table 68. Enoxaparin Sodium APIs and Preparations Market: Company Product Type Footprint
Table 69. Enoxaparin Sodium APIs and Preparations Market: Company Product Application Footprint
Table 70. Enoxaparin Sodium APIs and Preparations New Market Entrants and Barriers to Market Entry
Table 71. Enoxaparin Sodium APIs and Preparations Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Enoxaparin Sodium APIs and Preparations Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Enoxaparin Sodium APIs and Preparations Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Enoxaparin Sodium APIs and Preparations Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Enoxaparin Sodium APIs and Preparations Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Enoxaparin Sodium APIs and Preparations Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Enoxaparin Sodium APIs and Preparations Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Enoxaparin Sodium APIs and Preparations Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Enoxaparin Sodium APIs and Preparations Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Enoxaparin Sodium APIs and Preparations Raw Material
Table 131. Key Manufacturers of Enoxaparin Sodium APIs and Preparations Raw Materials
Table 132. Enoxaparin Sodium APIs and Preparations Typical Distributors
Table 133. Enoxaparin Sodium APIs and Preparations Typical Customers

LIST OF FIGURES

Figure 1. Enoxaparin Sodium APIs and Preparations Picture
Figure 2. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Type in 2022
Figure 4. 20 mg/0.2mL Examples
Figure 5. 40 mg/0.4mL Examples
Figure 6. 60 mg/0.6mL Examples
Figure 7. 80 mg/0.8mL Examples
Figure 8. 100 mg/1mL Examples
Figure 9. 120 mg/0.8mL Examples
Figure 10. 150 mg/1mL Examples
Figure 11. 300mg/3mL Examples
Figure 12. Global Enoxaparin Sodium APIs and Preparations Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Application in 2022
Figure 14. Deep Vein Thrombosis Examples
Figure 15. Pulmonary Embolism Examples
Figure 16. Others Examples
Figure 17. Global Enoxaparin Sodium APIs and Preparations Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Enoxaparin Sodium APIs and Preparations Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Enoxaparin Sodium APIs and Preparations Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Enoxaparin Sodium APIs and Preparations Average Price (2018-2029) & (US$/Unit)
Figure 21. Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Enoxaparin Sodium APIs and Preparations by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Enoxaparin Sodium APIs and Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Enoxaparin Sodium APIs and Preparations Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Enoxaparin Sodium APIs and Preparations Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Enoxaparin Sodium APIs and Preparations Average Price by Application (2018-2029) & (US$/Unit)
Figure 39. North America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Region (2018-2029)
Figure 59. China Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Enoxaparin Sodium APIs and Preparations Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Enoxaparin Sodium APIs and Preparations Market Drivers
Figure 80. Enoxaparin Sodium APIs and Preparations Market Restraints
Figure 81. Enoxaparin Sodium APIs and Preparations Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Enoxaparin Sodium APIs and Preparations in 2022
Figure 84. Manufacturing Process Analysis of Enoxaparin Sodium APIs and Preparations
Figure 85. Enoxaparin Sodium APIs and Preparations Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source


More Publications